Investigator-Initiated Clinical Trial AgreementInvestigator-Initiated • March 22nd, 2022
Contract Type FiledMarch 22nd, 2022This Investigator-Initiated Clinical Trial Agreement (“Agreement”) is made as of this {DAY} day of {MONTH}, {YEAR} (the “Effective Date”) by and between the Board of Regents of the University of Wisconsin System on behalf of the University of Wisconsin-Madison, a public higher educational institution with an address at 21 N. Park Street Suite 6301, Madison, WI 53715 (“Institution”) and {COMPANY NAME}, a corporation having its principal place of business at {COMPANY ADDRESS} (“Company”). Company and Institution are herein referred to collectively as “Parties.” Individually, each of Institution and Company is a “Party.”
Investigator-Initiated Clinical Trial AgreementInvestigator-Initiated • February 21st, 2022
Contract Type FiledFebruary 21st, 2022This Investigator-Initiated Clinical Trial Agreement (“Agreement”) is made as of this {DAY} day of {MONTH}, {YEAR} (the “Effective Date”) by and between the Board of Regents of the University of Wisconsin System on behalf of the University of Wisconsin-Madison, a public higher educational institution with an address at 21 N. Park Street Suite 6301, Madison, WI 53715 (“Institution”) and {COMPANY NAME}, a corporation having its principal place of business at {COMPANY ADDRESS} (“Company”). Company and Institution are herein referred to collectively as “Parties.” Individually, each of Institution and Company is a “Party.”